ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TBPH Theravance Biopharma Inc

9.20
-0.32 (-3.36%)
After Hours
Last Updated: 16:21:03
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Theravance Biopharma Inc TBPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.32 -3.36% 9.20 16:21:03
Open Price Low Price High Price Close Price Prev Close
9.51 9.15 9.52 9.20 9.52
more quote information »

Recent News

Date Time Source Heading
4/10/202406:00PRNUSTheravance Biopharma, Inc. to Host Virtual Key Opinion..
2/26/202416:16EDGAR2Form 8-K - Current report
2/26/202416:05PRNUSTheravance Biopharma, Inc. Reports Fourth Quarter and Full..
2/22/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202420:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202406:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
2/16/202420:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/14/202416:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202406:00PRNUSTheravance Biopharma to Report Fourth Quarter and Full Year..
1/16/202406:16EDGAR2Form 8-K - Current report
1/05/202406:07EDGAR2Form 8-K - Current report
1/05/202406:00PRNUSTheravance Biopharma Announces Results from the Phase 4..
12/28/202306:01EDGAR2Form 8-K - Current report
12/26/202318:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202318:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/21/202317:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/21/202317:06EDGAR2Form 8-K - Current report
12/21/202317:00PRNUSTheravance Biopharma, Inc. Announces Appointment of Jeremy..
12/18/202306:00PRNUSTheravance Biopharma to Conduct Investor Meetings During the..
11/22/202318:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202318:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202318:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202306:00PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
11/15/202306:00PRNUSTheravance Biopharma to Participate in the 6th Annual..
11/13/202308:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
11/09/202316:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202316:53EDGAR2Form 8-K - Current report
11/07/202316:28PRNUSTheravance Biopharma, Inc. Reports Third Quarter 2023..
11/01/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202317:15EDGAR2Form 8-K - Current report
10/19/202306:00PRNUSTheravance Biopharma to Report Third Quarter 2023 Financial..
10/18/202318:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/16/202316:13EDGAR2Form 144 - Report of proposed sale of securities
9/18/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202316:24EDGAR2Form 144 - Report of proposed sale of securities
9/12/202306:05EDGAR2Form 8-K - Current report
8/29/202306:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
8/28/202306:05PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
8/24/202318:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202318:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202318:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202318:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202318:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202318:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202317:00EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock